What is the management of septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Septic Shock

Septic shock requires immediate, aggressive resuscitation with crystalloid fluids, early broad-spectrum antibiotics within the first hour, prompt source control, and norepinephrine as first-line vasopressor when hypotension persists despite adequate fluid resuscitation. 1

Immediate Resuscitation (First 3 Hours)

Fluid Therapy

  • Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours using either balanced crystalloids or normal saline as first-choice fluids 2, 1
  • Continue fluid administration using a challenge technique—give additional fluids as long as hemodynamic parameters continue to improve 1, 3
  • Use dynamic measures of fluid responsiveness (e.g., passive leg raise, pulse pressure variation) rather than static measures like central venous pressure when available 1, 3
  • Consider adding albumin when patients require substantial amounts of crystalloids 1
  • Avoid hydroxyethyl starches completely—they increase acute kidney injury and mortality risk 2, 1

Antimicrobial Therapy

  • Administer broad-spectrum antimicrobials within the first hour of recognition of septic shock 2, 1, 4
  • Obtain at least two sets of blood cultures before starting antimicrobials if this does not significantly delay therapy 1, 3
  • Empiric coverage must be broad enough to cover all likely pathogens including gram-negative bacteria, gram-positive organisms, and potentially fungal or viral pathogens based on clinical syndrome, patient history, and local epidemiology 2
  • If vascular access is difficult, consider intraosseous access or intramuscular administration of appropriate β-lactams (cefepime, ceftriaxone, ertapenem, imipenem/cilastatin) 2, 1
  • Reassess antimicrobial regimen daily for de-escalation once pathogen identification and sensitivities are established 2, 1

Source Control

  • Identify the specific anatomic diagnosis requiring source control as rapidly as possible and implement intervention within 12 hours of diagnosis 2, 1, 3
  • Use the intervention associated with the least physiologic insult (e.g., percutaneous drainage rather than surgical drainage when feasible) 2
  • Remove intravascular access devices promptly if they are a possible source after establishing alternative vascular access 2, 1

Vasopressor Therapy

First-Line Agent

  • Initiate norepinephrine as the first-choice vasopressor if the patient remains hypotensive despite adequate fluid resuscitation 2, 1, 3, 4
  • Target a mean arterial pressure (MAP) of at least 65 mmHg 2, 1, 3
  • Vasopressors can be safely administered through a peripheral 20-gauge or larger IV line if central access is not immediately available 4

Second-Line Agents

  • Add vasopressin (0.01-0.04 units/min) to norepinephrine when an additional agent is needed to maintain adequate blood pressure or to decrease norepinephrine dosage 2, 3, 4
  • Consider epinephrine as a third-line agent if hypotension persists despite norepinephrine and vasopressin 3, 4
  • Avoid dopamine except in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia 3

Inotropic Support

  • Do not routinely use inotropes 2
  • Consider dobutamine when low cardiac output is accompanied by central venous oxygen saturation (ScvO2) below 70% despite adequate fluid resuscitation and vasopressor use 2
  • The combination of dobutamine and norepinephrine is recommended as first-line treatment when inotropic support is needed 2

Refractory Septic Shock

Corticosteroid Therapy

  • Administer hydrocortisone 200-300 mg/day for at least 5 days, followed by a tapering dose, in patients with refractory shock not responding to adequate fluid resuscitation and vasopressors 2, 3, 4
  • Consider adding fludrocortisone in refractory cases 4

Additional Rescue Therapies

  • Consider terlipressin (boluses of 1-2 mg) as rescue therapy in cases of refractory shock 2
  • Evaluate for and reverse reversible causes: pneumothorax, pericardial tamponade, or endocrine emergencies 3

Ongoing Monitoring and Reassessment

Hemodynamic Targets

  • Monitor MAP ≥ 65 mmHg 2, 1
  • Maintain SpO2 ≥ 95% 2
  • Target urine output ≥ 0.5 mL/kg/hour 2
  • Guide resuscitation to normalize lactate levels as a marker of tissue hypoperfusion 1, 3, 4
  • Assess mental status and capillary refill time as clinical markers of adequate perfusion 4

Monitoring for Complications

  • Reassess hemodynamic status frequently through clinical examination and available physiologic variables 1, 3
  • Monitor for signs of fluid overload including hepatomegaly and rales, particularly after aggressive resuscitation 3
  • Avoid fluid overresuscitation—it can delay organ recovery, prolong ICU stay, and increase mortality 1, 3

Pediatric-Specific Considerations

  • Use the same initial fluid resuscitation approach (30 mL/kg within first 3 hours) 1
  • Norepinephrine remains the first-line vasoactive agent 2
  • Consider phosphodiesterase III inhibitors in cases with low cardiac output and normal arterial pressure 2, 3
  • Hydrocortisone dosing: 1 mg/kg every 6 hours for refractory shock 2
  • Begin peripheral inotropic support until central venous access can be obtained in children not responsive to fluid resuscitation 3

Critical Pitfalls to Avoid

  • Never delay antimicrobial administration—each hour of delay is associated with increased mortality 2, 4
  • Do not use antimicrobial agents in patients with severe inflammatory states determined to be of noninfectious cause 2, 1
  • Do not rely solely on static measures like central venous pressure to guide fluid therapy 1, 3
  • Recognize that the standard 30 mL/kg fluid recommendation may need modification in patients with low ejection fraction—consider smaller boluses with frequent reassessment and earlier vasopressor initiation 1
  • Do not delay source control interventions—implement within 12 hours when feasible 2, 1, 3

References

Guideline

Management of Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Refractory Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergency medicine updates: Management of sepsis and septic shock.

The American journal of emergency medicine, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.